700+
Corporations
About AtomDeep
Scientific spirit · International innovation · All in AI
700+
Corporations
100+
Listed companies
30W+
Scientists
100%
Launch success rate
Knowledge is the spark that advances civilization. From ancient archives to modern search engines, every transformation in the medium of knowledge has significantly unleashed human potential. Today, we are entering an era where big data and AI are deeply integrated. The internal R&D data and knowledge of enterprises have become their most valuable assets and competitive barriers. AI for Science has become a global consensus. Standardized, complete, traceable, and inheritable R&D data form the cornerstone of safety compliance, the accumulation of wisdom, and continuous innovation. We are dedicated to building a leading R&D data and AI infrastructure, helping enterprises and research institutions efficiently document, deeply mine, and securely preserve their core R&D knowledge. By tailoring AI-powered professional large models for our clients, we ensure that every exploration moves forward on a solid foundation of wisdom. Ensuring that R&D is supported by data, enriched by intelligence, aided by AI, and guided toward a promising future — this is AtomDeep's mission and our steadfast commitment.
By 2030, empower half the world's scientists with electronic lab notebooks.
We are committed to achieving the goal of "affordable, accessible, and effective" through our independently developed laboratory digital products, such as ELN, structure editors, and sequence editors
AtomDeep was founded by scientists from the world's top pharmaceutical companies. Our core team brings together scientists and engineers in chemistry and biology from prestigious institutions such as Peking University, Fudan University, Shanghai Jiao Tong University, Zhejiang University, and Fortune 500 companies. We deeply understand the challenges of scientific research and the needs of innovation. It is this "By Scientists, For Scientists" ethos that drives us to refine our products with the dedication of "ten years of sharpening a sword," striving to provide solutions that are closest to the real-world scenarios of scientific research.
Founded in Zhangjiang Hi-Tech Park, Shanghai, China Secured angel funding
InDraw V1.0 Molecule Editor & ELN V1.0 ELN launched Completed Pre-A funding; Received Shanghai Innovation Fund Launched Inventory, Project, Registry V1.0
Received National Key R&D Program funding from MOST World's first IUPAC Chinese naming technology Partnered with: XtalPi(02228.HK), Abbisko(02256.HK), RADIANT INC(Korea), Staidson Biopharma (USA), SparX Therapeutics (USA)
Completed Series B funding (led by SIG) Launched InPaper V1.0 (AI literature data extraction) Partnered with: Sturcture (NASDAQ: GPCR), Duality Biologics (09606.HK), Everest Medicines (01952.HK), GenFleet Therapeutics (2595.HK)
Scientific research AI large model AtomDeep AI 2.0 launched InDraw Structural Formula Editor 7.0 goes live Cooperated with Clarins, Fosun Pharmaceutical and Zhendong Pharmaceutical Entered overseas markets such as France, Germany and Japan
Enable half the world's scientists to use Electronic Lab Notebooks
With the Electronic Lab Notebook (AtomDeep) ELN as its core and InAI as the intelligent engine, AtomDeep has developed a comprehensive and independently controlled product matrix for laboratory digitalization and AI integration. This matrix covers the entire lifecycle of R&D data generation, management, analysis, and collaboration.
AtomDeep products have successfully served over 700 top-tier R&D institutions, including more than 100 listed companies, covering cutting-edge fields such as small molecule pharmaceuticals, large biomolecules, gene and cell therapy, synthetic biology, advanced materials, and semiconductors. Since 2019, our products have expanded into global markets, including the United States, France, Germany, Singapore, South Korea, and Japan. Representative Clients Include: Huawei, Yangtze River Pharmaceutical Group, Fosun Pharma, Hutchison Whampoa, Mindray Medical, XtalPi, Insilico Medicine, CNOOC, Huafon Group, Institutes of the Chinese Academy of Sciences, Structure (USA), ADARx (USA), and Clarins (France). We believe that the choices of our peers are the strongest testament to quality.
We actively collaborate with outstanding partners across various fields, opening our AI capabilities to jointly provide customers with more comprehensive solutions.